![](/wp-content/uploads/2019/09/easd-announcement.png)
$599
New T2DM Reversal Program Launched; Positive Interim Data from Ph1b/2a T1DM Study; EASD 2021 Key Press Releases (Oct 1)
On the final day of EASD 2021, two key press releases were observed from Gini Health and Precigen ActoBio. Below FENIX provides insights and context from the respective announcements.